News

Rezera Inc. filed Amendment No. 2 to its Form S-1 registration statement with the SEC on November 9, 2026, covering a proposed initial public offering of 16,666,667 shares of common stock at a preliminary price range of $11.00 to $13.00 per share on the …

Jiangsu Hengrui Pharmaceuticals Co., Ltd. filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 7,420,091 shares of common stock in Braveheart Bio, Inc. (NASDAQ:BRVE), representing 8.2% of the company's outstanding shares as of September 30, 2026.

ConnectM Technology Solutions, Inc. filed Amendment No. 4 to its Form S-1 registration statement with the U.S. Securities and Exchange Commission on November 6, 2026, covering a proposed firm commitment public offering of up to 3,735,000 shares of common stock and accompanying warrants.

Citigroup Global Markets Holdings Inc. filed a Free Writing Prospectus on November 6, 2026, disclosing the offering summary for Contingent Income Callable Securities due November 2028, linked to the worst performing of the EURO STOXX 50, Russell 2000, and S&P 500 indices.

HSBC Holdings plc filed a Form 6-K with the SEC on 9 November 2026 announcing an investor and analyst briefing on its UK business, hosted by HSBC UK Bank plc CEO David Lindberg and CFO Jonathan Bingham at the company's London office.

Windward Bio Group AG filed Amendment No. 2 to its Form F-1 registration statement with the U.S. Securities and Exchange Commission on November 9, 2026, covering a proposed initial public offering of 10,294,117 common shares at an estimated price range of $16.00 to $18.00 …

Artificial Intelligence Technology Solutions Inc. filed a current report on November 9, 2026, disclosing a press release from its RAD division announcing a new product called RAIA, described as a security tower designed for self-setup by the end user.